Kanjin Therapeutics
PrivateLast Round
Seed
Apr 27, 2026
Total Funding Raised
$330,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kanjin Therapeutics is a biotechnology company developing advanced therapeutics to halt and potentially restore kidney function, with the goal of eliminating the need for dialysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kanjin Therapeutics Comparables
Compare Kanjin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| R1 Therapeutics | 81% | |
| Walden Biosciences | 81% | |
| Rege Nephro Co., Ltd. | 78% |
Kanjin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 27, 2026 |
Kanjin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kyoto University Innovation Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
$330K round led by Kyoto University Innovation Capital
Kanjin Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kanjin Therapeutics's valuation, stock price, and market status.
Is Kanjin Therapeutics a public or private company?
Kanjin Therapeutics is a private company.
What is the current stock price of Kanjin Therapeutics?
Kanjin Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Kanjin Therapeutics worth (valuation)?
Valuation information for Kanjin Therapeutics is not publicly available.
Can I buy Kanjin Therapeutics stock?
Kanjin Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kanjin Therapeutics's last funding round?
Funding round information for Kanjin Therapeutics is not publicly available.
Who are the main investors in Kanjin Therapeutics?
Investor information for Kanjin Therapeutics is not publicly disclosed.
Will Kanjin Therapeutics IPO soon?
No public IPO plans have been announced for Kanjin Therapeutics.
How can I track Kanjin Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kanjin Therapeutics's secondary market activity and sign up for updates.